ロード中...
Rapid de-localization of actin leading edge components with BDM treatment
<p>Abstract</p> <p>Background</p> <p>2,3-Butanedione monoxime (BDM) has been widely used as a non-muscle myosin inhibitor to investigate the role of non-muscle myosinII in the process of actin retrograde flow and other actin cytoskeletal processes. Recent reports show t...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2003-06-01
|
| シリーズ: | BMC Cell Biology |
| オンライン･アクセス: | http://www.biomedcentral.com/1471-2121/4/5 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|